Literature DB >> 8549347

Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400mg.

R Garraffo1, H B Drugeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549347     DOI： 10.2165/00003495-199500492-00084

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.

Authors:  R Garraffo; H B Drugeon; P Dellamonica; E Bernard; P Lapalus
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

2.  Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections.

Authors:  S Kljucar; M Heimesaat; E von Pritzbuer; J Timm; H Scholl; D Beermann
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965
  2 in total
  1 in total

Review 1.  A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.

Authors:  Jan-Frederik Schlender; Donato Teutonico; Katrin Coboeken; Katrin Schnizler; Thomas Eissing; Stefan Willmann; Ulrich Jaehde; Heino Stass
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.